Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath is a leader in Robotic Process Automation. The company plans to decentralize, improve sales fundamentals, and innovate in AI and automation to address execution challenges. Despite recent ...

UiPath's share price has plummeted since IPO, but we see it as a key AI winner for 2025 and beyond. PATH's RPA 'ai agents' automate more business processes than ever, making it indispensable despite ...

let's talk about the third quarter because it was your first profitable third quarter. Um, you saw enterprises accelerating their spending on your automation, um um software and strategies. So, do you ...